Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06449378 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia

Study acronym: RECOVER
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 15, 2026 (before its estimated September 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv10
  2. Primary completion date: Sep 1, 2025 to Sep 15, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 19 to 13
    v9
  3. Study sites: 18 to 19v8
  4. Study sites: 17 to 18
    • Primary completion date: Mar 31, 2026 to Sep 1, 2025
    • Study completion date: Jun 30, 2031 to Oct 1, 2030
    v7
  5. Study sites: 12 to 17v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 11 to 12v5
  2. Study sites: 6 to 11v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 6
    • Start date changed from estimate of Jun 1, 2024 to Jul 2, 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of RECOVER is to evaluate the performance and safety of Transorb™ self-gripping resorbable mesh in high-risk subjects (at least one risk factor impairing wound healing) when used for reinforcement of abdominal wall soft tissues in procedures involving open extraperitoneal ventral hernia repair, in clean (US); and clean and clean-contaminated (Europe) surgical fields (Centers for Disease Control and Prevention (CDC) Classification I and II. Data from this study will primarily be used to support market approval and European post-market clinical follow-up needs. Secondarily, data will be used for product marketing, future product development, and to support market release and maintenance in global geographies.
Trial Details
NCT Number NCT06449378
Lead Sponsor Medtronic - MITG
Conditions
(from sponsor)		 Hernia, Hernia, Ventral, Hernia, Abdominal, Hernia Abdominal Wall
Related terms Hernia, Hernia, Abdominal, Hernia, Ventral
Enrollment 163 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov